References
Moriwaki K, Kayashima K. Prolonged neuromuscular blockade and insufficient reversal after sugammadex administration in cesarean section under general anesthesia: a case report. JA Clin Rep. 2019;5:28.
Ezri T, Evron S, Petrov I, Schachter P, Berlovitz Y, Shimonov M. Residual Curarization and postoperative respiratory complications following laparoscopic sleeve gastrectomy. The effect of reversal agents: sugammadex vs. neostigmine. J Crit Care Med. 2015;1:61–7.
Brvar M, Chan MY, Dawson AH, Ribchester RR, Eddleston M. Magnesium sulfate and calcium channel blocking drugs as antidotes for acute organophosphorus insecticide poisoning - a systematic review and meta-analysis. Clin Toxicol. 2018;56:725–36.
Takagi S, Adachi YU, Saubermann AJ, Vizi ES. Presynaptic inhibitory effects of rocuronium and SZ1677 on [3H]acetylcholine release from the mouse hemidiaphragm preparation. Neurochem Int. 2002;40:655–9.
Murata T, Kubodera T, Ohbayashi M, Murase K, Adachi YU, Matsuda N. Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia. Can J Anesth. 2013;60:508–9.
Sung TY, You HJ, Cho CK, Choi HR, Kim YB, Shin YS, Yang HS. Effects of magnesium chloride on rocuronium-induced neuromuscular blockade and sugammadex reversal in an isolated rat phrenic nerve-hemidiaphragm preparation: an in-vitro study. Eur J Anaesthesiol. 2018;35:193–9.
Thevathasan T, Shih SL, Safavi KC, Berger DL, Burns SM, Grabitz SD, Glidden RS, Zafonte RD, Eikermann M, Schneider JC. Association between intraoperative non-depolarising neuromuscular blocking agent dose and 30-day readmission after abdominal surgery. Br J Anaesth. 2017;119:595–605.
Esteves S. Can residual paralysis be avoided?: a critical appraisal of the use of sugammadex. Eur J Anaesthesiol. 2015;32:663–5.